Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pear Therapeutics Inc | PEAR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.2578 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2578 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.20 - 6.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.2578 | USD |
Pear Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 36.10M | 140.03M | 71.46M | $ 4.21M | $ 201.56k | -0.57 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 10.19M | 6.30% |
Pear Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PEAR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.60 | 0.625 | 0.20 | 0.324914 | 4,961,154 | -0.3422 | -57.03% |
| 1 Month | 1.04 | 1.07 | 0.20 | 0.3700362 | 1,314,702 | -0.7822 | -75.21% |
| 3 Months | 1.00 | 1.34 | 0.20 | 0.5479787 | 620,604 | -0.7422 | -74.22% |
| 6 Months | 1.47 | 3.33 | 0.20 | 1.00 | 406,819 | -1.21 | -82.46% |
| 1 Year | 4.65 | 6.74 | 0.20 | 1.80 | 381,187 | -4.39 | -94.46% |
| 3 Years | 10.20 | 14.60 | 0.20 | 2.98 | 401,539 | -9.94 | -97.47% |
| 5 Years | 10.20 | 14.60 | 0.20 | 2.98 | 401,539 | -9.94 | -97.47% |
Pear Therapeutics Description
| Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital therapeutics. It focuses to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. |